Intelerad Awarded US Department of Veterans Affairs National Teleradiology Program Contract

Intelerad Medical Systems(tm), a leader in medical imaging PACS, RIS and workflow solutions, today announced that the United States Department of Veterans Affairs (VA) has selected IntelePACS(r) as the picture archiving and communications system (PACS) for their National Teleradiology Program (NTP).

"We are honored that the VA has selected Intelerad to deliver the technology and solutions required to support a first-class teleradiology program," said Randall Oka, President and CEO, Intelerad. "Our solutions' architecture is particularly suited for highly-distributed environments and proven to deliver high-performance in large-scale deployments, which will be ideal for the NTP."

As the Veteran's Health Administration's in-house teleradiology service, the NTP provides 24-hour teleradiology service to nationwide VA facilities.

"In deploying IntelePACS, the VA's radiologists will benefit from a comprehensive reading and reporting platform with a single worklist, integrated voice recognition and specialty modules," said Oka.

For more information, on Intelerad's teleradiology solutions, click here<http://www4.intelerad.com/e/5662/-intelepacs-teleradiology-html/vgvn2/797106775>.

To request a demo of Intelerad solutions at RSNA 2013, visit Intelerad's RSNA microsite<http://www4.intelerad.com/e/5662/2013-11-12/vgvn4/797106775>.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.